![]() |
Name |
2-Dodecenoic acid
|
Molecular Formula | C12H22O2 | |
IUPAC Name* |
(E)-dodec-2-enoic acid
|
|
SMILES |
CCCCCCCCC/C=C/C(=O)O
|
|
InChI |
InChI=1S/C12H22O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h10-11H,2-9H2,1H3,(H,13,14)/b11-10+
|
|
InChIKey |
PAWGRNGPMLVJQH-ZHACJKMWSA-N
|
|
Synonyms |
2-Dodecenoic acid; Dodec-2-enoic acid; (E)-dodec-2-enoic acid; trans-2-Dodecenoic acid; 32466-54-9; 4412-16-2; (2E)-dodec-2-enoic acid; (2E)-2-Dodecenoic acid; trans-dodec-2-enoic acid; 2E-Lauroleic acid; 2E-Dodecenoic acid; (E)-2-dodecenoic acid; 1289-45-8; C12:1n-10; TRANS-2-DODECENOICACID; 2-Dodecensaeure; 2t-Dodecensaeure; Dodec-2-ensaeure; Dodec-2-enoicacid; EINECS 224-569-1; Dodecen-(2t)-saeure; trans-2-lauroleic acid; 12:1, n-10 trans; C12:1, n-10 trans; CHEMBL4281333; CHEBI:37162; CHEBI:38371; DTXSID401343611; AMY37907; ZINC1689827; LMFA01030788; MFCD00045906; NSC 59856; AKOS008105134; AS-57983; WS-00320; AI3-11152; C12:1; CS-0152270; D5660; EN300-65552; EN300-365600; W16764; A826494; A934942; Q27117056; Q27117632; Z336127680; 3X1
|
|
CAS | 1289-45-8 | |
PubChem CID | 5282729 | |
ChEMBL ID | CHEMBL4281333 |
Chemical Classification: |
|
|
---|
Molecular Weight: | 198.3 | ALogp: | 4.8 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 14 | QED Weighted: | 0.439 |
Caco-2 Permeability: | -4.648 | MDCK Permeability: | 0.00002280 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.104 |
Blood-Brain-Barrier Penetration (BBB): | 0.768 | Plasma Protein Binding (PPB): | 96.48% |
Volume Distribution (VD): | 0.321 | Fu: | 3.13% |
CYP1A2-inhibitor: | 0.073 | CYP1A2-substrate: | 0.211 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.282 |
CYP2C9-inhibitor: | 0.205 | CYP2C9-substrate: | 0.977 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.104 |
CYP3A4-inhibitor: | 0.018 | CYP3A4-substrate: | 0.033 |
Clearance (CL): | 4.313 | Half-life (T1/2): | 0.797 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.02 |
Drug-inuced Liver Injury (DILI): | 0.021 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.026 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.871 | Carcinogencity: | 0.267 |
Eye Corrosion: | 0.992 | Eye Irritation: | 0.992 |
Respiratory Toxicity: | 0.289 |